1-3 of 3
Wenjuan Yu, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic Significance of IDH1 and IDH2 mutations in Older Patients with Primary Cytogenetically Normal Acute Myeloid Leukemia

Jinghan Wang, PhD, Zhixin Ma, PhD, Qinrong Wang, Mengxia Yu, PhD, Xiufeng Yin, PhD, Xia Li, PhD, Shanshan Suo, Dan Shen, Yungui Wang, PhD, Xin Huang, Hanzhang Pan, Huanping Wang, Zhimei Chen, MD, Jiansong Huang, PhD, Liping Mao, Wenjuan Yu, MD, Juying Wei, MD, Wenbin Qian, Wenyuan Mai, MD, Haitao Meng, MD, Hongyan Tong, MD, Suning Chen, Guido Marcucci, MD, Saijuan Chen, Jie Jin, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5058.
https://doi.org/10.1182/blood.V128.22.5058.5058
Published: 2016
Journal Articles

Homoharringtonine in Combination with Cytarabine and Aclarubicin in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia: a Single-Center Experience

Wenjuan Yu, MD, Liping Mao, MD, Jiejing Qian, MD, Wenbin Qian, MD, Haitao Meng, MD, Wenyuan Mai, MD, Hongyan Tong, MD, Yin Tong, MD, Jie Jin, MD
Journal: Blood
Blood (2011) 118 (21): 2595.
https://doi.org/10.1182/blood.V118.21.2595.2595
Published: 2011
Journal Articles

Results of Acute Myeloid Leukemia Treated with Triple-Drug Regimen Based on HA as Induction Chemotherapy and Its Relationship with Karyotype.

Jianxiang Wang, MD, Yingchang Mi, MD, Yangping Xue, MD, Wenjuan Yu, MD, Shougeng Bian, MD
Journal: Blood
Blood (2005) 106 (11): 4595.
https://doi.org/10.1182/blood.V106.11.4595.4595
Published: 2005